About Epcoritamab
Class: | Monoclonal antibody (anti-CD3 and anti-CD20)
Use: | Treatment of adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)
Adult dose: | Initial dose of 1 mg administered subcutaneously, followed by a step-up dosing schedule to 60 mg; maintenance dose of 60 mg administered subcutaneously every 4 weeks
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Cytokine release syndrome, infusion-related reactions, fatigue, nause
Drug Class
Monoclonal antibody (anti-CD3 and anti-CD20)
Uses & Indications
Treatment of adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: AbbVie Deutschland GmbH & Co. KG [Ludwigshafen;Germany], Germany
Package Size
1 Glass Vial (0.8 mL)
Price & Supplier
Price in UAE: AED 40898.00
Dosage Information
Adult Dose
Initial dose of 1 mg administered subcutaneously, followed by a step-up dosing schedule to 60 mg; maintenance dose of 60 mg administered subcutaneously every 4 weeks
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Cytokine release syndrome, infusion-related reactions, fatigue, nausea, headache, rash, and increased risk of infections
Contraindications & Precautions
Hypersensitivity to epcoritamab or any component of the formulation; active infections
Important Warnings
Monitor for signs of cytokine release syndrome; may cause severe or life-threatening infections; caution in patients with a history of autoimmune disease or prior malignancies
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.